Anacor Pharmaceuticals (ANAC)
|
3.55
-0.14 (-3.79%)
|
|
|
|
ANAC additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
ANAC Profile
•
Exchange
NASDAQ
•
Sector
Not Available
•
Industry
Not Available
•
Held by these Mutual Funds
Not Available
•
Executives
Mr. David P. Perry M.B.A.
Chief Exec. Officer
Pres and Director
Dr. Lucy Shapiro Ph.D.
Co-Founder
Co-Chair of Scientific Advisory Board Director and Member of Nominating and Corp. Governance Committee
Mr. Geoffrey M. Parker
Chief Financial Officer
Principal Accounting Officer and Sr. VP
Dr. Jacob J. Plattner Ph.D.
Sr. VP of Research
Dr. Irwin A. Heyman Ph.D.
Sr. VP of Drug Devel.
Chief Exec. Officer
Pres and Director
Dr. Lucy Shapiro Ph.D.
Co-Founder
Co-Chair of Scientific Advisory Board Director and Member of Nominating and Corp. Governance Committee
Mr. Geoffrey M. Parker
Chief Financial Officer
Principal Accounting Officer and Sr. VP
Dr. Jacob J. Plattner Ph.D.
Sr. VP of Research
Dr. Irwin A. Heyman Ph.D.
Sr. VP of Drug Devel.
•
Employee Count
80
Special Offers
Competitors
ANAC earnings
Date
Actual
Expected
Prev Yr Qtr
11/7/2012
-0.46
-0.45
-0.16
8/9/2012
-0.47
-0.45
-0.54
5/10/2012
-0.48
-0.43
-0.49
